Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 1 Unknown
75 enrolled
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 2 Unknown
43 enrolled 9 charts
NICE-40
Phase 1/2 Unknown
30 enrolled
R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase NA Unknown
60 enrolled
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
Phase 2 Unknown
41 enrolled
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
Phase 2 Unknown
27 enrolled
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Phase 2 Unknown
108 enrolled
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
Phase 2 Unknown
47 enrolled
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Phase 3 Unknown
637 enrolled 18 charts
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.
Phase 2 Unknown
100 enrolled
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
Phase 2 Unknown
134 enrolled
VIDL+ASCT
Phase 2 Unknown
27 enrolled
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Phase 2 Unknown
45 enrolled
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Phase 2 Unknown
90 enrolled
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
Phase 2 Unknown
120 enrolled
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Phase 1/2 Unknown
46 enrolled
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum
Phase NA Unknown
100 enrolled
IVAM
Phase 2 Unknown
30 enrolled
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Phase 4 Unknown
200 enrolled
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
Phase 2 Unknown
70 enrolled
Response-based Treatment of High-risk Neuroblastoma
Phase 2 Unknown
54 enrolled
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
Phase 1/2 Unknown
45 enrolled
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
Phase NA Unknown
96 enrolled
SIOPCNSGCTII
Phase 4 Unknown
400 enrolled
NACOPRAD
Phase 3 Unknown
534 enrolled
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Phase 3 Unknown
1,200 enrolled
PICASSO
Phase 2 Unknown
67 enrolled
Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
Phase 1 Unknown
24 enrolled
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
Phase 2 Unknown
30 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
Phase 2 Unknown
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
Phase 3 Unknown
150 enrolled
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 3 Unknown
1,800 enrolled
Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
Phase 3 Unknown
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
Phase 2 Unknown
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
Phase 3 Unknown
430 enrolled
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Phase 3 Unknown
105 enrolled
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
Phase 2 Unknown
60 enrolled
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Phase 2 Unknown
150 enrolled
Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
Phase 3 Unknown
600 enrolled
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
Phase 2 Unknown
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
Phase 2 Unknown
260 enrolled
Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer
Phase 2 Unknown
42 enrolled
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Phase 2/3 Unknown
241 enrolled
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Phase 3 Unknown
642 enrolled
GemTIP
Phase 1/2 Unknown
23 enrolled
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Phase 2 Unknown
120 enrolled
SSGXX
Phase 2 Unknown
188 enrolled
ZOL
Phase 2/3 Unknown
60 enrolled
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
Phase 2 Unknown
30 enrolled
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
Phase 4 Unknown
25 enrolled